Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and ...

Biogen and AbbVie have announced the voluntary withdrawal of their multiple sclerosis drug Zinbryta from all markets worldwide following dangerous brain inflammation in seven patients in Europe.

Cayuga Health Systems is to separately receive $1.5 million in Tompkins Community Grant funding to support an intensive ...

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of ...

Medication for opioid use disorder can save lives. But fewer than half of jails surveyed across the country provide it, a new ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.

Scientific Advisory Committee (SAC) has developed a withdrawal guidance for two additional substances, Dimethyl Sulfoxide ...